Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Reset all filters
01 2Athena Pharmaceutiques
02 7Cohance Lifesciences
03 12Orion Corporation
04 26Granules India Limited
05 32care4
06 7Actavis Inc
07 13Ajanta Pharma Limited
08 7Alkem Laboratories
09 7Alvogen
10 6Amneal Pharmaceuticals
11 20Apotex Inc
12 9Assia Chemical Industries Ltd
13 1Azurity Pharma
14 8Ebb Medical
15 7Elite Laboratories
16 1FrostPharma AB
17 1Frostpharma Ab
18 7Hikma Pharmaceuticals
19 7Lannett Company, Inc.
20 6MSN Laboratories
21 13Mallinckrodt Pharmaceuticals
22 6Medartuum
23 10ORIFARM GROUP AS
24 7PRO DOC LIMITEE
25 7Prinston
26 7RHODES PHARMACEUTICALS LP
27 6SHIRE PLC
28 6STADA Arzneimittel
29 32Sandoz B2B
30 6Spirig Healthcare
31 13Sun Pharmaceutical Industries Limited
32 59Takeda Pharmaceutical
33 6Takeda Pharmaceuticals Australia Pty. Ltd.
34 6Taro Pharmaceutical Industries
35 22Teva Pharmaceutical Industries
36 7Viatris
Reset all filters
01 3CAP
02 35CAPSULE
03 118CAPSULE;ORAL
04 77Capsule
05 6Capsule, hard
06 12Hard Capsule
07 7Immediate Release Capsule
08 6Immediate Release Chewable Tablet
09 35Kapsel, hard
10 1Mixture, solution
11 1Oral Solution
12 2Oral-Dispersible Tablet
13 1SOLUTION;ORAL
14 18TABLET (CHEWABLE)
15 42TABLET, CHEWABLE;ORAL
16 3capsule
17 3Blank
Reset all filters
01 12Allowed
02 49Approved
03 22Deregistered
04 3Originator
05 161RX
06 123Blank
Reset all filters
01 7APO-LISDEXAMFETAMINE CAPSULES
02 6APO-LISDEXAMFETAMINE CHEWABLE TABLETS
03 1ARYNTA
04 6Adixel
05 11Aduvanz
06 12Balidax
07 12Dexhility
08 38Elvanse
09 14Elvanse Vuxen
10 147LISDEXAMFETAMINE DIMESYLATE
11 1Lisarol
12 6Lisdexamfetamin Orion Pharma
13 2Lisdexamfetamin Spirig HC
14 2Lisdexamfetamine
15 13Lisdexamfetamine Dimesylate
16 6Lisdexamfetamine Orion
17 4Lisdexamfetamine Spirig HC
18 3Oferlanz
19 3Offerlanz
20 7PRO-LISDEXAMFETAMINE
21 7SANDOZ LISDEXAMFETAMINE CAPSULES
22 1Silaroza
23 6TARO-LISDEXAMFETAMINE CHEWABLE TABLETS
24 7TEVA-LISDEXAMFETAMINE
25 26VYVANSE
26 6Volidax
27 6Vyvanse
28 1Vyvanse 30
29 1Vyvanse 50
30 1Vyvanse 70
31 7Blank
Reset all filters
01 6Australia
02 53Canada
03 2France
04 20India
05 42Norway
06 3South Africa
07 71Sweden
08 12Switzerland
09 161USA
Regulatory Info :
Registration Country : France
Brand Name : Lisdexamfetamine
Dosage Form : Oral-Dispersible Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 20mg
Packaging :
Approval Date : 04/01/2024
Application Number : 2.02211E+13
Regulatory Info : Approved
Registration Country : Sweden
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info : RX
Registration Country : USA
Brand Name : LISDEXAMFETAMINE DIMESYLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2025-01-29
Application Number : 218987
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : France
Brand Name : Lisdexamfetamine
Dosage Form : Oral-Dispersible Tablet
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : France
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 60MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 70MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 30mg
Packaging :
Approval Date : 04/01/2024
Application Number : 2.02211E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 40mg
Packaging :
Approval Date : 04/01/2024
Application Number : 2.02211E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 50mg
Packaging :
Approval Date : 04/01/2024
Application Number : 2.02211E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 60mg
Packaging :
Approval Date : 04/01/2024
Application Number : 2.02211E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamin Orion Pharma
Dosage Form : Capsule
Dosage Strength : 70mg
Packaging :
Approval Date : 04/01/2024
Application Number : 2.02211E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 20mg
Packaging :
Approval Date : 30/01/2023
Application Number : 2.02108E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 30mg
Packaging :
Approval Date : 30/01/2023
Application Number : 2.02108E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 40mg
Packaging :
Approval Date : 30/01/2023
Application Number : 2.02108E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Lisdexamfetamine Orion
Dosage Form : Capsule
Dosage Strength : 50mg
Packaging :
Approval Date : 30/01/2023
Application Number : 2.02108E+13
Regulatory Info : Approved
Registration Country : Sweden